Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pharmatherapeutica
|
January 1, 1981
Treatment of severe essential hypertension with labetalol: effect on active and inactive renin
J H Hauger-Klevene
Current Medical Research and Opinion
|
January 1, 1981
Renin levels and cardiovascular morbidity: a prospective study of the effect of beta-adrenergic blocking drugs
J H Hauger-Klevene
Clinical Science and Molecular Medicine. Supplement
|
December 1, 1976
Deoxycorticosterone measured by a radioimmunoassay in vivo in rats undergoing adrenal regeneration
J H Hauger-Klevene, P Vecsei
European Journal of Clinical Pharmacology
|
January 1, 1985
Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine one year
J H Hauger-Klevene, J C Scornavacchi
Cardiology
|
January 1, 1987
Coronary heart disease mortality and coronary risk factors in Argentina
J H Hauger-Klevene, E C Balossi
International Journal of Clinical Pharmacology Research
|
January 1, 1983
Abnormal prolactin response to thyrotrophic releasing hormone in essential hypertension
J H Hauger-Klevene, M B Pinkas
Drug and Alcohol Dependence
|
January 1, 1987
Liver cirrhosis mortality in Argentina: its relationship to alcohol intake
J H Hauger-Klevene, E C Balossi
Hypertension (Dallas, Tex. : 1979)
|
November 1, 1981
Blood pressure and prolactin: effects of guanfacine. Three-year follow-up study
J H Hauger-Klevene, M B Pinkas, S Gerber
Cor Et Vasa
|
January 1, 1987
Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment
J H Hauger-Klevene, E C Balossi, J C Scornavacchi
The American Journal of Cardiology
|
March 28, 1986
Effects of guanfacine on growth hormone, prolactin, renin, lipoproteins and glucose in essential hypertension
J H Hauger-Klevene, E C Balossi, J C Scornavacchi
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pharmatherapeutica
|
January 1, 1981
Treatment of severe essential hypertension with labetalol: effect on active and inactive renin
J H Hauger-Klevene
Current Medical Research and Opinion
|
January 1, 1981
Renin levels and cardiovascular morbidity: a prospective study of the effect of beta-adrenergic blocking drugs
J H Hauger-Klevene
Clinical Science and Molecular Medicine. Supplement
|
December 1, 1976
Deoxycorticosterone measured by a radioimmunoassay in vivo in rats undergoing adrenal regeneration
J H Hauger-Klevene, P Vecsei
European Journal of Clinical Pharmacology
|
January 1, 1985
Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine one year
J H Hauger-Klevene, J C Scornavacchi
Cardiology
|
January 1, 1987
Coronary heart disease mortality and coronary risk factors in Argentina
J H Hauger-Klevene, E C Balossi
International Journal of Clinical Pharmacology Research
|
January 1, 1983
Abnormal prolactin response to thyrotrophic releasing hormone in essential hypertension
J H Hauger-Klevene, M B Pinkas
Drug and Alcohol Dependence
|
January 1, 1987
Liver cirrhosis mortality in Argentina: its relationship to alcohol intake
J H Hauger-Klevene, E C Balossi
Hypertension (Dallas, Tex. : 1979)
|
November 1, 1981
Blood pressure and prolactin: effects of guanfacine. Three-year follow-up study
J H Hauger-Klevene, M B Pinkas, S Gerber
Cor Et Vasa
|
January 1, 1987
Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment
J H Hauger-Klevene, E C Balossi, J C Scornavacchi
The American Journal of Cardiology
|
March 28, 1986
Effects of guanfacine on growth hormone, prolactin, renin, lipoproteins and glucose in essential hypertension
J H Hauger-Klevene, E C Balossi, J C Scornavacchi
Page
of 2